There we have it in black and white. The CEO of the company that manufactures drugs like Ozempic says that GLP-1 drugs are not a cure-all, and patients will still need other treatments. Surely now Mr. Market will realize that the panicky sell off of RMD is the result of fearmongering. Meanwhile I see the 28% fall in RMD's share priced as one of those rare share market opportunities to 'buy when everyone is fearful'. Its time for me to back up the truck!
There we have it in black and white. The CEO of the company that...
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$28.38 |
Change
0.050(0.18%) |
Mkt cap ! $17.98B | |||
| Open | High | Low | Value | Volume |
| $28.50 | $28.52 | $28.34 | $31.67M | 1.114M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1580 | $28.38 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $28.39 | 1050 | 1 |
View Market Depth
| Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
| RMD (ASX) Chart |